New FDA Rules Are Boon To Medical Mobile App Developers
On Aug. 1, 2014, the U.S. Food and Drug Administration released draft guidance that would exempt from premarket 510(k) review many low-risk medical devices, including certain mobile applications that can convert...To view the full article, register now.
Already a subscriber? Click here to view full article